From: Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis
Acceptance Rate
Total Number
Overall Rate
Overall Voluntary Acceptance within 5 min
1533
91.6%
Overall Consumption with Assistancea
134
8.0%
Overall Non-consumption
6
0.4%